This is how EMA chooses its new executive director
Thursday, two candidates face their perhaps most important exam to date, when they have to convince the European Medicines Agency that they should be the agency's new executive director. DMA's director general, Thomas Senderovitz, sits on the board of the EMA and he provides and insight into the process before, during and after.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY IDA JACOBSEN & JONAS SAHL JØRGENSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.